Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant

作者: Carlos Alonso Bedate , Manuel Soto Álvarez , Daniel Ruiz Abánades

DOI:

关键词: Ribosomal proteinVirologyBiologyParasitic diseaseAdjuvantBiochemistry

摘要: The invention relates to composition comprising a RPE and optionally Th1-promoting adjuvant for the preparation of medicament treatment or prevention parasitic disease its use.

参考文章(58)
S. Iborra, D. R. Abánades, N. Parody, J. Carrión, R. M. Risueño, M. A. Pineda, P. Bonay, C. Alonso, M. Soto, The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers. Clinical and Experimental Immunology. ,vol. 150, pp. 375- 385 ,(2007) , 10.1111/J.1365-2249.2007.03501.X
Steven G. Reed, Davin C. Dillon, Yasir A. W. Skeiky, Antonio Campos-Neto, John R. Webb, Leishmania antigens for use in the therapy and diagnosis of leishmaniasis ,(2001)
J R Webb, D Kaufmann, S G Reed, A Campos-Neto, Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. Journal of Immunology. ,vol. 157, pp. 5034- 5041 ,(1996)
Peter Probst, Erika Stromberg, Hashim W. Ghalib, Michelle Mozel, Roberto Badaro, Steven G. Reed, John R. Webb, Identification and Characterization of T Cell-Stimulating Antigens from Leishmania by CD4 T Cell Expression Cloning Journal of Immunology. ,vol. 166, pp. 498- 505 ,(2001) , 10.4049/JIMMUNOL.166.1.498
Alfonso R. Gennaro, Joseph P. Remington, Remington's pharmaceutical sciences Published in <b>1975</b> in Easton Pa) by Mack. ,(1985)
Hermann Wagner, Susanne Hausmann, Martin Röcken, Grayson B. Lipford, Klaus Heeg, Oliver Egeter, Stefan Zimmermann, CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. Journal of Immunology. ,vol. 160, pp. 3627- 3630 ,(1998)
Nancy Noben-Trauth, Rosalia Lira, Hisashi Nagase, William E. Paul, David L. Sacks, The Relative Contribution of IL-4 Receptor Signaling and IL-10 to Susceptibility to Leishmania major Journal of Immunology. ,vol. 170, pp. 5152- 5158 ,(2003) , 10.4049/JIMMUNOL.170.10.5152
Kevin G. J. Pollock, Katherine S. McNeil, Jeremy C. Mottram, Russell E. Lyons, James M. Brewer, Phillip Scott, Graham H. Coombs, James Alexander, TheLeishmania mexicanaCysteine Protease, CPB2.8, Induces Potent Th2 Responses The Journal of Immunology. ,vol. 170, pp. 1746- 1753 ,(2003) , 10.4049/JIMMUNOL.170.4.1746
E Pateraki, R Portocala, H Labrousse, J L Guesdon, Antiactin and antitubulin antibodies in canine visceral leishmaniasis. Infection and Immunity. ,vol. 42, pp. 496- 500 ,(1983) , 10.1128/IAI.42.2.496-500.1983
R COLER, S REED, Second-generation vaccines against leishmaniasis Trends in Parasitology. ,vol. 21, pp. 244- 249 ,(2005) , 10.1016/J.PT.2005.03.006